Objective: Aging is an important risk factor of nonalcoholic fatty liver disease (NAFLD).Here, we investigated whether the deficiency ofnicotinamide adenine din
Nicotinamide phosphoribosyltransferase (NAMPT), a rate-limiting enzyme in mammalian NAD biosynthesis, has become an attractive target for drug discovery.Activat